Molina CC, Cárdenas ABA

Language: Spanish
References: 21
Page: 1-13
PDF size: 260.58 Kb.

ABSTRACT

Treatment of clinically significant diabetic macular edema is the topic of our review. This condition is the first cause of vision loss in diabetic patients. Treatment options include anti-VEFG drugs, steroids and surgery (vitrectomy with internal limiting membrane peeling). There is no an ideal treatment at present. Optic coherence tomography is a useful tool to predict final vision in these patients.

REFERENCES

1. Greene C, Brown D, Wallace J, et al. Comparative accuracy of 3 blood glucose monitoring systems that communicate with an insulin pump. Endocrine Pract. 2014;20:1016-21.

2. Barría F, Martínez F. Guía práctica clínica de retinopatía diabética para Latinoamérica. Iapb.org; 2011 [acceso: 04/06/2018]. Disponible en: https://www.iapb.org/wp-content/uploads/Guia-Practica-Clinica-de-Retinopatia-Diabetica-para-Latinoamerica.pdf

3. Coleman AL. Diabetic Retinopathy. Elsevier; 2017.

4. Wilkinson CP, Hinton DR, Wiedeman P, et al. Diabetic Retinopathy. Ryan's Retina. 2018. p. 3305-93.

5. Price LD, Au S, Chong NV. Optomap ultrawide field imaging identifies additional retinal abnormalities in patients with diabetic retinopathy. Clin Ophthalmol. 2015;9:527-31.

6. Talks SJ, Manjunath V, Steel DH, et al. New vessels detected on wide-field imaging compared to two-field and seven field imaging: implications for diabetic retinopathy screening image analysis. Br J Ophthalmol. 2015;99(12):1606-09.

7. Gross JG, Glassman AR, Jampol LM, et al. Panretinal photocoagulation vs. intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA. 2015;314(20):2137-46.

8. Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of diabetes and its burden in the United States. Atlanta: CDC; 2015.

9. Wilkinson CP, Hinton DR, Srini VRS, Wiedeman P. Telescreening for diabetic retinopathy. Ryan's Retina; 2018. p. 3421-39.

10. Consejo Internacional de Oftalmología. Guías clínicas para el manejo de la patología ocular del diabético. Consejo Internacional de Oftalmología; 2017.

11. Verdaguer J, Martínez FG, Barria F. Actualización de la Guía clínica de retinopatía diabética para Latinoamérica. Consejo Internacional de Oftalmología; 2016.

12. Diabetic Retinopathy Clinical Research Network. Aflibercept, bevacizumab or ranibizumab for diabetic macular edema. N Eng J Med. 2015;372:1193-1203.

13. Tan GS, Cheung N, Simon R, Cheung Wong TY. Diabetic macular edema. Lanc Diab Endocrinol. 2017;5(2):143-55.

14. Cohen SR, Gardner WT. Diabetic retinopathy and diabetic macular edema. In: Cohen SR. Retinal Pharmacotherapeutics. Karger Publishers; 2016. p. 137-46.

15. Modarres M. Vitrectomy for diabetic macular edema; where are we? J Curr Ophthalmol. 2016;28(4):161.

16. Simunovic MP, Hunyor AP, Ho IV. Vitrectomy for diabetic macular edema: a systematic review and meta-analysis. Can J Ophthalmol. 2014;49(2):188-95.

17. Jackson TL, Nicod E, Angelis A, Grimaccia F, Pringle E, Kanavos P. Pars plana vitrectomy for diabetic macular edema: a systematic review, meta-analysis, and synthesis of safety literature. Retina. 2017:37(5):886-95.

18. Schmidt-Erfurtha U, García-Arumib J, Bandelloc F, Bergd K, Chakravarthye U, Bianca S. Guidelines for the management of diabetic macular edema by the European Society of Retina Specialists (EURETINA). Ophthalmologica. 2017;237:185-222.

19. Jia Y, Bailey ST, Hwang TS, et al. Quantitative optical coherence tomography angiography of vascular abnormalities in the living human eye. EE.UU.: Proc Natl Acad Sci. 2015;112: 2395-402.

20. Ishibazawa A, Nagaoka T, Takahashi A, et al. Optical coherence tomography angiography in diabetic retinopathy: a prospective pilot study. Am J Ophthalmol. 2015;160:35-44.

21. Musat O, Colta D, Cernat C, Boariut AM, Alexandru L, Raluca Georgescu R, et al. New perspectives in retina imagin-angio OCT. Rim J Ophathalmol. 2016;60(2):63-7.